Register entry

El-Peptido (Shanghai) Biopharmaceutical Co., Ltd

Data as of · How to read this entry

Registered sites
1
Active NDC listings
25
Live patents
0
Countries
1
Base
China
Authorisation

Registered operations

Analytical testing1Active ingredient (API) manufacture1
Sites

Registered establishments

1
EstablishmentAddressRegistered forFEI / DUNS
El-Peptido (Shanghai) Biopharmaceutical Co., LtdRoom 107, Building 1, Lane 295, Rongle East Road, Songjiang District, Shanghai, Shanghai 201600, China (CHN)Analytical testing, Active ingredient (API) manufacture3043327690519639621
Catalogue

Drug listings by form and route

25

25 active NDC listings: 25 bulk ingredient. By marketing category: BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING 25.

Dosage formNDCs
powder25
RouteNDCs
Labeller name on the listingNDCs
el-peptido (shanghai) biopharmaceutical co., ltd25
Catalogue

Marketed products

25
BrandGeneric nameForm / routeNDC
-AOD 9604 Acetatepowder87370-001BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-BPC-157 Acetatepowder87370-002BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-Bremelanotide Acetatepowder87370-022BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-CJC-1295 Acetatepowder87370-003BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-Copper Peptide(GHK-Cu)powder87370-031BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-DIHEXA Acetatepowder87370-032BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-DSIP Acetatepowder87370-026BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-ELAMIPRETIDE ACETATEpowder87370-135BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-EPITALON Acetatepowder87370-027BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-GHRP-2powder87370-021BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-Gonadorelin Acetatepowder87370-028BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-IPAMORELIN Acetatepowder87370-011BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-KPVpowder87370-023BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-MELANOTAN IIpowder87370-019BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-MITOCHONDRIA-DERIVED PEPTIDE MOTS-Cpowder87370-010BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-Oxytocinpowder87370-018BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-SELANK Acetatepowder87370-013BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-SEMAGLUTIDEpowder87370-005BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-SEMAX Acetatepowder87370-014BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-Sermorelin Acetatepowder87370-006BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-TB-500powder87370-017BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-TIRZEPATIDEpowder87370-008BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-Tesamorelin Acetatepowder87370-007BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-Thymosin Alpha-1 Acetatepowder87370-012BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-Thymosin Beta-4 Acetatepowder87370-009BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
Neighbours

Registered in the same town

12
Compare

Comparable companies in China

Enquiry

Common questions

Is El-Peptido (Shanghai) Biopharmaceutical Co., Ltd FDA approved?
El-Peptido (Shanghai) Biopharmaceutical Co., Ltd holds 1 FDA-registered establishment in China. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are El-Peptido (Shanghai) Biopharmaceutical Co., Ltd's drugs manufactured?
The FDA register lists Shanghai. Registered operations: analytical testing, active ingredient (API) manufacture.
What drugs does El-Peptido (Shanghai) Biopharmaceutical Co., Ltd make?
25 products are listed under El-Peptido (Shanghai) Biopharmaceutical Co., Ltd in the openFDA NDC Directory, most often as powder. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.